High Blood Pressure

High Blood Pressure Hypertension

Hypertension or high blood pressure is known as the "silent killer" because despite being one of the most common fatal conditions worldwide, most people are unaware they have the condition because it presents with very few or no symptoms.

What Causes High Blood Pressure?

Hypertension Symptoms and Effects

Hypertension Diagnosis

Hypertension Treatment

Anti-Hypertensive Drugs

High Blood Pressure in Children

Link between Bisphenol A and Increase in Blood Pressure

Hypertension Risk Factors

Ambulatory Blood Pressure Monitoring

Are Blood Pressure Monitors Accurate?

What is Obesity?

See more featured articles »

Causes of Obesity and Overweight

Obesity, What Can be Done?

What is Body Mass Index (BMI)?

Obesity and Fast Food

Obesity and Exercise

Obesity Management

Obesity and Blood Pressure

Obesity and Metabolic Syndrome

Obesity Epidemiology

What is Obesity Paradox?

Obesity and Periodontitis

Obesity in Children

Obesity and Respiratory Disorders

Obesity and Heart Disease

Obesity and Anesthesia

Obesity and Skin Problems

Fat Mass and Obesity-Associated Gene (FTO)

What does Sleeve Gastrectomy Involve?

Dieting for Obese Children

Abdominal Obesity and the Metabolic Syndrome

DASH Diet for High Blood Pressure

Solitary Kidney and High Blood Pressure Monitoring

Causes of angina

Risk Factors for Atherosclerosis

High Cholesterol and Stroke Risk

Latest High Blood Pressure News and Research

Newly identified mechanism regulates activity of nitric oxide-producing enzyme

The liver filters blood, detoxifies chemicals and metabolizes drugs. Hepatitis, alcohol and primary liver diseases are common sources of damage in the liver and can result in scarring, known as fibrosis.

5 Jun 2020

Effects of chronic stress associated with increased inflammatory signaling within brain circuits

Anxiety and depression are significantly heightened during times of great stress such as the COVID-19 pandemic.

4 Jun 2020

Spine surgeons across the world are experiencing the effects of COVID-19

Spine surgeons across the world are experiencing effects of COVID-19, including canceled procedures, changes in clinical roles, anxiety and risk of exposure to the disease themselves due to insufficient protective equipment. An international team of researchers reported these findings recently in the Global Spine Journal.

3 Jun 2020

Data provides a baseline understanding of the eating habits of older adults before COVID-19

Most people in their 50s and older were capable home cooks just before COVID-19 struck America, but only 5% had ordered groceries online, according to a new national poll.

2 Jun 2020

No specific COVID-19-linked lesions found despite extensive organ injury

A recent paper published online on the preprint server medRxiv in May 2020 reports autopsy results on COVID-19 patients. The paper concludes that there were no specific hallmark lesions of COVID-19 in any of the many organs found to be injured by the infection in patients who died of the disease.

1 Jun 2020

Identifying optimal vasopressor treatment for nontraumatic subarachnoid hemorrhage

Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).

30 May 2020

Temple research suggests new way to prevent abdominal aortic aneurysm therapeutically

The main thoroughfare that carries oxygen-rich blood from the heart to the abdomen is known as the abdominal aorta.

28 May 2020

Type 2 diabetes is more prevalent in American Indians and Alaska Natives

Type 2 diabetes (T2D) affects American Indians and Alaska Natives at approximately three times the rate of white Americans and is closely linked to the disproportionately high rates of cardiovascular diseases such as heart attacks and strokes, according to the American Heart Association Scientific Statement "Cardiovascular Health in American Indians and Alaska Natives," published today in the Association's flagship journal Circulation.

28 May 2020

ACE2 receptors in the kidney not linked to high BP or RAS blockers

Even as the COVID-19 pandemic continues to smolder and flare up in various parts of the world, researchers are still trying to make sense of the virus, its routes of spread, its target tissues, and the immune responses it induces. One crucial piece of knowledge is that the primary viral receptor is a human enzyme called angiotensin-converting enzyme 2 (ACE2).

27 May 2020

Study shows antihypertensive drugs do not raise serum levels of ACE2

A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).

26 May 2020

New NIH grant will help Pennington Biomedical scientists to study metabolic diseases

A new federal grant will allow young scientists to delve into the mechanisms of emotional eating and preeclampsia and other disorders not considered "classic" metabolic diseases.

26 May 2020

Researchers find a 'skinny' gene

Some people may have trouble losing weight, while others find it hard to gain weight. Now, a team of scientists may have found the answer to why some people remain thin despite eating without restriction.

26 May 2020

Kidney transplants: Volume of services correlated with quality of treatment outcomes

In complex operations, is there a correlation between the volume of service provided per hospital and the quality of the treatment outcome? This question is addressed in eight commissions on minimum volumes that the Federal Joint Committee has issued to the Institute for Quality and Efficiency in Health Care.

22 May 2020

New clinical trial to test treatment that targets overactive immune response to COVID-19

For some COVID-19 patients, the body's immune response may be as destructive as the virus that causes the disease.

22 May 2020

Despite low stroke rates among COVID-19 patients, cases are still more severe

The rate of strokes in COVID-19 patients appears relatively low, but a higher proportion of those strokes are presenting in younger people and are often more severe compared to strokes in people who do not have the novel coronavirus.

22 May 2020

Lowering blood pressure reduces risk of developing dementia, research shows

Research completed in NUI Galway has shown that lowering blood pressure by taking blood pressure medications reduces the risk of developing dementia and cognitive impairment by 7%.

21 May 2020

Research looks at COVID-19 in cancer patients

As the world grapples with the COVID-19 pandemic, new questions arise as to the risk posed by the virus to different patient populations, including the elderly and those with underlying disease. A new study published on the preprint server medRxiv* in May 2020 deals with the risk of COVID-19 in the subgroup of patients with cancer.

21 May 2020

Study focuses on COVID-19 patients with inflammatory rheumatic diseases

The ongoing COVID-19 pandemic has caused nearly five million cases and over 327,000 deaths worldwide. The signs and symptoms of this disease are varied, although there are typical features which assist diagnosis.

20 May 2020

Taking blood pressure medicines as usual is important during COVID-19 pandemic

Keeping your blood pressure under control is especially important during the COVID-19 pandemic – so keep taking your blood pressure medicines!

20 May 2020

MicroRNAs in maternal blood may predict development of preeclampsia

Small non-coding RNA molecules, called microRNAs (miRNAs), found and measured in the blood plasma of asymptomatic pregnant women may predict development of preeclampsia, a condition characterized by high blood pressure and abnormal kidney function that affects roughly 5 to 8 percent of all pregnancies.

20 May 2020